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Cooling and hypothermia are profoundly neuropro-
tective, mediated, at least in part, by the cold
shock protein, RBM3. However, the neuroprotective
effector proteins induced by RBM3 and the mecha-
nisms by which mRNAs encoding cold shock pro-
teins escape cooling-induced translational repres-
sion are unknown. Here, we show that cooling
induces reprogramming of the translatome, includ-
ing the upregulation of a new cold shock protein,
RTN3, a reticulon protein implicated in synapse for-
mation. We report that this has two mechanistic
components. Thus, RTN3 both evades cooling-
induced translational elongation repression and is
also bound by RBM3, which drives the increased
expression of RTN3. In mice, knockdown of
RTN3 expression eliminated cooling-induced neuro-
protection. However, lentivirally mediated RTN3
overexpression prevented synaptic loss and cogni-
tive deficits in a mouse model of neurodegenera-
tion, downstream and independently of RBM3. We
conclude that RTN3 expression is a mediator of
RBM3-induced neuroprotection, controlled by novel
mechanisms of escape from translational inhibition
on cooling.
INTRODUCTION
Therapeutic hypothermia is a powerful neuroprotectant, acting
through multiple mechanisms, although the underlying path-
ways are not fully understood [1, 2]. We recently showed that
the cold shock RNA-binding protein, RBM3, plays a critical
role in mediating synaptic repair processes essential for neuro-
protection in mouse models of neurodegenerative disease [3].
Thus, the inability to induce RBM3 expression in early disease
results in defective structural synaptic plasticity and hence
reduced regenerative capacity, leading to synapse loss and
eventually neuronal loss. Inducing endogenous RBM3 expres-638 Current Biology 27, 638–650, March 6, 2017 ª 2017 The Author(
This is an open access article under the CC BY license (http://creativesion in vivo through cooling, or by lentiviral-mediated overex-
pression, prevented synapse loss in prion and Alzheimer-type
mice, rescued memory deficits, protected against neurodegen-
eration, and significantly prolonged survival [3]. How RBM3
mediates these effects is unknown, although it is likely to be
related to its RNA chaperone function, as it facilitates selective
mRNA translation following a number of cellular stresses,
including cooling [4–6]. RBM3 is also implicated in protection
against cell death [7, 8] and increases local protein synthesis
at dendrites [9].
Upon cooling, the changes to the protein synthesis machin-
ery are similar to those observed with other stress inducers
(e.g., UVB exposure) [10, 11] and include phosphorylation of
eukaryotic initiation factor 2 (eIF2) on the alpha subunit
[12, 13]. However, cold shock differs because relieving eIF2a-
mediated inhibition of translation is insufficient to restore pro-
tein synthesis rates [12]. Instead, the rapid reduction in protein
synthesis that accompanies cooling [12–15] is a result of a
decrease in translational elongation mediated by the phosphor-
ylation of elongation factor 2 (eEF2) by elongation factor 2 ki-
nase (eEF2K; a negative regulator of eEF2) [12]. Importantly,
suppression of eEF2K and subsequent reactivation of eEF2
significantly increases the rate of protein synthesis rates in
cooled cells [12], consistent with the concept that elongation
is a major regulatory node under specific pathophysiological
conditions [16, 17].
To examine the relationship between cold stress, RBM3 in-
duction, and the modulation of mRNA translation for the synthe-
sis of putative neuroprotective proteins, we investigated the
post-transcriptional response to hypothermia in vitro and vali-
dated the data in vivo in a mouse model of neurodegeneration,
in which we know cooling is protective, mediated by RBM3.
We show that, following cold shock/cooling, the global decrease
in protein synthesis rates is associated with selective reprogram-
ming of the translatome. We find enhanced synthesis of specific
proteins: not only the cold shock protein RBM3 (as predicted) but
also of a number of proteins with a role in development and func-
tion of the nervous system, including reticulon 3 (RTN3). RTN3
has a role in synaptic plasticity and synapse formation [18, 19]
and is thus a compelling candidate for the neuroprotective
effects mediated by increased RBM3 expression. We find that
both RBM3 and RTN3 evade translational repression and thats). Published by Elsevier Ltd.
commons.org/licenses/by/4.0/).
Figure 1. Mild Cooling Results in Translation Regulation of a Defined Set of Transcripts
(A) Protein synthesis rates determined by [35S]-methionine label incorporation after 24 hr incubation of HEK293 cells at 32C. Values were normalized to cells
incubated at 37C. Error bars represent SE within three independent experiments.
(B) HEK293 cells were incubated at 37C or at 32C for 24 hr and immunoblotted for RBM3 and CIRP, eIF2 alpha eEF2, and b-actin.
(legend continued on next page)
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RBM3 binds RTN3mRNA and plays a major role in driving cool-
ing-induced upregulation of RTN3 expression. Finally, we show
that RTN3 expression, downstream of RBM3 induction, medi-
ates cooling-induced neuroprotection in mice with neurodegen-
erative disease and importantly is neuroprotective even in the
absence of cooling.
RESULTS
Cooling Induces Reprogramming of the Translatome
Both transcriptional and post-transcriptional control mecha-
nisms are required for the overall response to cell stress [20].
In order to examine the genome-wide changes accompanying
cooling, we incubated HEK293 cells at 32C for 24 hr. This re-
sulted in reduction in protein synthesis (Figure 1A) and phos-
phorylation of the translation initiation and elongation factors
eIF2a and eEF2 (Figure 1B; in agreement with previous studies
[12]). We chose HEK293 cells because the response to cooling
is well documented [12, 15, 21] and, in addition, they express
many markers associated with neuronal lineage [22]; thus, using
this cell line increases the potential for the identification of cold-
induced putative neuroprotective proteins. Transcriptional ana-
lyses of the cooled HEK293 cells showed that 119 genes were
downregulated at the transcriptional level, with no significant in-
creases in transcription of any mRNAs (Figure S1; Table S1). In
addition, no differences greater than 2-fold were identified in
the expression of microRNAs (miRNAs) (Table S2). These data
support regulation of protein synthesis as an important mecha-
nism for control of gene expression following cooling. We have
shown previously that cooling reduces global rates of protein
synthesis and importantly that elongation repression is the driver
of this process (Figures 1A and 1B [12]). We hypothesize that,
during cooling, specificmRNAs are able to evade a global reduc-
tion in translation elongation so that the expression of the corre-
sponding proteins is maintained or even increased. However,
identifying such mRNAs represents a technical challenge. Under
conditions in which the initiation of translation is inhibited, the
number of actively translating ribosomes decreases [10, 23]
and polysome profiling can be used to identify those mRNAs
that remain polysomally associated; this generally correlates
with increased synthesis of the corresponding proteins [20].
However, under conditions in which elongation is inhibited, the
number of polysomally associated ribosomes will stay the
same or increase, and therefore it is difficult to identify mRNAs
that either escape or are relatively insensitive to elongation
slow down. Therefore, to identify proteins whose synthesis
was increased during cooling, computational modeling was
used in conjunction with polysome profiling.(C) Sucrose density gradient ultracentrifugations were performed fromHEK293 ce
subpolysomes (40S, 60S, and 80S) and polysomes. Northern analysis was carrie
(D) mRNAs from gradient fractions were pooled and subjected to cDNA microarra
fractions, normalized log2 (polysome/subpolysome) value; yellow is polysome- a
(E) mRNAs that showed significant change in polysome/subpolysome (P/S) ratio o
with decreased polysomal-associated transcripts, obtained from the ingenuity pa
p < 0.05) for each biological function represented in the red bar chart. The blue l
(F) Predictive modeling of transcript-decoding speed was performed on the initial
polysomal association. The boxplot showsmRNAs that have a decrease in polyso
[NOG]) compared to those that contain ‘‘fast’’ codons, such as LDHA.
See also Figures S1–S3 and Tables S1–S6.
640 Current Biology 27, 638–650, March 6, 2017Sucrose density gradient analysis was carried out on cooled
samples to separate polysomes and the associated transcripts
(Figure 1C), which were subsequently purified and analyzed by
cDNA microarray. By microarray 71, mRNAs were identified
that were associated with a decreased number of polysomes
at 32C (Figures 1D and S2; Tables S3 and S4). Importantly, in-
genuity pathway analysis showed that there was significant
enrichment for mRNAs that encode proteins that function in
the nervous system and its development (15/71; marked by an
arrow, Figure 1E). To predict which of these neuronal-related
mRNAswere translated in cooled cells, we used a computational
model of elongation control [24] generated by defining the intra-
cellular concentration of ribosomes, translation factors, and
tRNAs (Table S5). The model allows the speed of decoding to
be estimated for any given open reading frame [25], assuming
that decoding speed is not significantly limited by tRNA-inde-
pendent parameters, such as mRNA secondary structure or
modifications. We have previously shown that, despite this
assumption, the model can be used to rank expression levels
from multiple elongation-controlled mRNAs reliably [25]. The
model predicts that, under eEF2 ablation, fast codons (which
are decoded by abundant tRNAs) change their elongation rate
by an order of magnitude, whereas slow codons are relatively
unaffected (see Figures S3A–S3C).
We applied the model to the transcripts that encoded mRNAs
with roles in neuronal processes identified by polysome profiling
(Figure 1D) to analyze elongation over the initial 20 codons (Fig-
ure 1F; Table S6). Our analysis showed that a subset of mRNAs,
including RTN3 and Noggin, contained codons that require less
abundant tRNAs in the 50 end of the transcripts (Figure 1F), and
our model predicted that these could escape the repression of
elongation.
mRNAs Encoding a Subset of Neuronal Proteins
Overcome Elongation Inhibition on Cooling
Western analysis showed that expression of Noggin and RTN3,
and as expected RBM3, increased at 32C, whereas GBBR1
and LDHA levels, which are encoded by mRNAs that contain co-
dons requiring abundant tRNAs, were unchanged in both cell
lines (Figure 2A). To confirm a post-transcriptional response,
we examined mRNA expression changes of RTN3 and Noggin
using qPCR (Figure 2B); there was a small reduction in the levels
of Noggin, consistent with the transcriptional profiling data
(Table S1; Figure S1) and no change for RTN3. There was an
increase in the expression of RBM3 mRNA, in agreement with
previous studies [4].
To confirm escape of translation elongation repression and
identifya strongcandidateproteinwithaneuroprotective function,lls incubated at 37Cor 32C for 24 hr. Plots show the distribution of RNAwithin
d out on individual fractions, which were probed for b-actin or PABP.
y. The color scale represents the ratio of mRNA in subpolysome and polysome
nd blue subpolysome-associated mRNAs.
n cooling were clustered into functional groups. Biological functions associated
thways analysis. Fisher’s exact test was used to calculate a p value (threshold
ine represents number of proteins per category.
20 codons of human transcript sequences from those that showed decreased
mal association and contain an initial 20 ‘‘slow’’ codons (e.g., RTN3 and Noggin
Figure 2. RTN3 Is Subject to Elongation Control
(A) Extracts from control or cooled HEK293 or SHSY5Y cells were immunoblotted for RTN3 and Noggin, GBBR1, and LDHA. b-actin is used as a loading control.
(B) qRT-PCR was performed on corresponding transcripts. Error bars represent 1 SD from themean within three independent experiments.GAPDHwas used as
a control.
(C) Protein synthesis rates determined by [35S]-methionine label incorporation after 24 hr incubation of HEK293 cells at 37C with cycloheximide. Values were
normalized to untreated cells. A two-tailed paired Student’s t test was used to calculate statistical significance. Error bars represent SE within three independent
experiments. **p < 0.001, all three conditions.
(D) Extracts from cells exposed to 10 mg/mL cycloheximide at 37C were immunoblotted for RTN3, c-Myc, and b-actin. Error bars represent 1 SD from the mean
within three independent experiments. *p < 0.01.
(E) eEF2 expression was reduced by siRNA, proteins extracted and immunoblotted with the antibodies shown.GAPDHwas used as a loading control. Error bars
represent 1 SD from the mean within three independent experiments. *p < 0.01.
See also Figures S4 and S5A.we focused on RTN3, a protein that has known function in
synaptogenesis in the adult nervous system [26–28] and a role
in neuroprotection. To reduce elongation by an alternative
method,we treatedcells grownat37Cwithcycloheximide,which
stalls the translocation step in the elongation cycle [29]. As ex-
pected, incubation with cycloheximide decreased global protein
synthesis rates (Figure 2C) and reduced expression of c-Myc,
which is known to have a short half-life of 20 min. However, there
was increased RTN3 expression, consistent with our model’sprediction that slowed elongation enhances synthesis of this pro-
tein (Figures 2D and S4).
To mimic the cooling-induced elongation block, we reduced
eEF2 expression by RNAi (Figure 2E). This resulted in an increase
in RTN3 levels, suggesting that the rate of elongation alongRTN3
mRNA is relatively unaffected by reduced availability of eEF2, in
agreement with our model (Figure S3).
Whereas we have shown previously there is a small effect
of cooling on the stability of specific proteins [21], RTN3 isCurrent Biology 27, 638–650, March 6, 2017 641
a relatively stable protein with a half-life of at least 24 hr, and
therefore, any effects of turnover in the time frame of the exper-
iment will be minimal (Figures S5A and S5B).
RBM3 Binds to RTN3 mRNA and Increases Its
Translation through trans-Acting Effects on Initiation
Cooling also reduces the rate of translation initiation, via inhibi-
tory phosphorylation of eIF2a (Figure 1A) [12], which compen-
sates for the reduction in translation elongation, as fewer
ribosomes will be available for initiation while they are limited
by globally reduced elongation speeds. A similar phenomenon
has been suggested to occur previously in yeast [25, 30]. Thus,
we predict that, in order to increase their translation, transcripts
also overcome the cooling-induced initiation block. This is likely
to be driven by trans-acting factors acting upon cis elements
within the transcripts. Because RBM3 is an RNA chaperone
whose expression is increased in cooled cells [31, 32] and is
known to mediate the neuroprotective effects of cooling [3],
we hypothesized that cooling-induced RBM3 may act as a
trans-acting factor promoting RTN3 translation and that some
of the neuroprotective effects of RBM3 may be mediated
through RTN3.
To address whether RBM3 interacted with RTN3 mRNA, we
carried out immunoprecipitation reactions, and data showed
that RBM3 binds toRTN3mRNA in both HEK293 cells and in hip-
pocampus of wild-typemice (Figures 3A and 3B). We then asked
whether RBM3 expression affects RTN3 levels in HEK293 cells
and mouse brain by transfecting with RBM3-expressing con-
structs or lentiviruses, respectively. In each case (Figures 3C
and 3D), the data show that overexpression of RBM3 resulted
in a dramatic increase in RTN3 protein expression, with no cor-
responding increase in RTN3 transcript levels in vitro (Figure 3C)
or in vivo (Figure 3D).
cis-Acting Elements in RTN3 Contribute to Evasion of
the Initiation Block
To examine the role of cis-acting elements in 50 UTR of RTN3 in
its post-transcriptional regulation by RBM3, we used a luciferase
reporter construct containing the RTN3 50 UTR (Figure 3E). At
25C, therewas a 5-fold increase in translation ofmessages con-
taining the 50 UTR of RTN3, compared to the control (Figure 3F).
Further, overexpression of RBM3 resulted in a 5-fold induction of
luciferase expression at 37C (Figure 3Gi). In contrast, RNAi of
RBM3 produced a small but significant reduction in luciferase
activity (Figure 3Gii). Taken together, the data support a role
for RBM3 in controlling RTN3 expression through the RTN3 50
UTR cis-regulatory sequence.
Cooling Induces RTN3 Expression In Vivo through
Post-transcriptional Mechanisms
Given the role of RBM3 in regulating RTN3 (Figures 2 and 3), we
focused on RTN3 as a potential mediator of the neuroprotective
effects of RBM3 induction. RTN3 is a strong candidate for this
role. It is a member of the reticulon family of proteins, with mul-
tiple functions in the nervous system, including axon and neurite
outgrowth [18, 19] and synapse formation [26–28]. It also has an
indirect role in synaptic plasticity through its inhibition of BACE1,
a secretase involved in cleavage of APP and a negative modu-
lator of pCREB levels [28, 33, 34].642 Current Biology 27, 638–650, March 6, 2017We testedwhether RTN3 expression was increased in brain on
cooling in vivo by inducing hypothermia in wild-type FVB mice
using 50 AMP, as described [3, 35]. We found the levels of both
RBM3 and RTN3 increased on cooling (Figure 4Ai) without corre-
sponding changes in respective mRNA levels (Figure 4Aii),
consistent with post-transcriptional upregulation. Further, cool-
ing induced a reduction in global protein synthesis rates to
40% of control levels (Figure 4B), as observed in vitro (Fig-
ure 1A) (although the abundance of polysomes was not reduced
to an equivalent extent [Figure 4C], again consistent with in vitro
findings [Figure 1C] [12]). Knockdown of RBM3 in mice via lenti-
virallymediated RNAi significantly reduced the RTN3 increase on
cooling (Figure 4D), confirming physiological relevance of this
functional interaction and suggesting that RTN3 expression is
downstream of RBM3 in cooling in vivo.
RTN3 Mediates Cooling-Induced Neuroprotective
Effects of RBM3
We next asked to what extent RTN3 is neuroprotective in mice
with neurodegenerative disease, using mice with prion disease,
specifically tg37 mice [36] inoculated with Rocky Mountain Lab-
oratory (RML) strain as in our previous studies [3, 37–41]. These
mice overexpress prion protein (PrP) and have a rapid disease
course, succumbing to disease in 12 weeks [36]. In these
mice, synaptic loss is associated with the failure to induce
RBM3 on cooling early in the disease course at 6 weeks post-
inoculation (w.p.i.) [3], developing behavioral deficits at
9w.p.i., with neuronal loss from 10w.p.i. In general, terminal clin-
ical signs appear at around 12 w.p.i.
We first confirmed that increased RTN3 expression is down-
stream of RBM3 in prion-diseased mice. Lentivirally mediated
RNAi of RTN3 reduced RTN3 levels in hippocampi (Figure 5A),
but not RBM3 levels (Figure 5A). Further, RNAi of RTN3 did not
affect high RBM3 levels induced by cooling while preventing,
as predicted, the cold-induced rise in RTN3 (Figure 5B). This
allowed us to address whether and to what extent RTN3
mediates the neuroprotective effects of RBM3. We found that
lentivirally mediated RNAi of RTN3 in prion-infected mice abol-
ished the protective effects of cooling on behavioral impairments
(Figure 5C), accelerated neuronal loss (Figure 5D), and abolished
the cooling-associated increase in survival in prion-infected
mice (Figure 5E). Thus, reducing levels of RTN3 largely abolished
the protective effects of high levels of cold-induced RBM3,
supporting the conclusion that RTN3 is a major mediator of the
effects of RBM3. Even in the absence of cooling, RNAi of
RTN3 accelerated synapse loss in disease (Figures S5C and
S5D), supporting a role for RTN3 in synapse maintenance and
formation/plasticity. However, the exact mechanism remains
unknown.
RTN3 Is Neuroprotective in Neurodegenerative Disease
RBM3 induction is profoundly neuroprotective in both prion and
5XFAD mice, effects that are abrogated if animals undergo
knockdown of RBM3 [3] or of RTN3 (Figures 5C–5E). To address
whether RTN3 is neuroprotective in the absence of cooling, we
injected prion-infected tg37 mice with lentiviruses overexpress-
ing RTN3 (LV-RTN3). This increased expression of RTN3 as
expected (Figure 6A), importantly without increasing RBM3
expression, consistent with RTN3 being downstream of RBM3
Figure 3. RTN3 Expression Is Downstream of RBM3
(A) Schematic representation of an RNA immunoprecipitation (RNA-IP) assay. Immunoblots of input lysate from HEK293 cells or hippocampus, immunopre-
cipitated with either rabbit IgG or RBM3 antibody, are shown.
(B) qRT-PCR was performed on RNA-IP samples using primers specific for human (HEK293) or mouse (hippocampus) samples. All values are normalized with
respect to the initial RNA input material, and the enrichment is plotted relative to GAPDH. A two-tailed paired Student’s t test was used to calculate statistical
significance. Error bars represent 1 SD from the mean within three independent experiments. **p < 0.01; ***p < 0.001.
(C) HEK293 cells were transfected with an expression plasmid construct encoding RBM3 or a control plasmid, and extracts were immunoblotted for RTN3.
b-actin was used as a loading control. RNA expression of RTN3 was assessed by qRT-PCR.
(D) Mouse hippocampi stereotaxically injected with lentivirus containing a construct to overexpress RBM3 and extracts were immunoblotted for RTN3 and
GAPDH. qRT-PCR was used to assess the expression of RTN3.
(E) Schematic representation of the RTN3 containing plasmid constructs encoding firefly luciferase.
(F) HEK293 cells were transfected with construct containing the 50 UTR of RTN3 and a Renilla luciferase control and incubated at either 37C or 25C for 24 hr.
Firefly luciferase activity was calculated relative to Renilla luciferase for each condition and expressed as the fold induction from 37C to 25C.
(Gi) HEK293 cells were transfected with either control (pcDNA3.1) or RBM3 expression plasmid (pcDNA-RBM3) and then transfected with either RTN3 50 UTR
pGL3 or pGL3 and Renilla luciferase constructs and luciferase activity determined. A two-tailed paired Student’s t test was used to calculate error. Error bars
represent 1 SD from the mean within three independent experiments. ***p < 0.001.
(Gii) HEK293 cells were transfected with either control siRNA (siCONT) or RBM3 siRNA (siRBM3) and then transfected with pGL3 and Renilla luciferase con-
structs. The fold repression from RTN3 50 UTR pGL3 compared to the control pGL3 was calculated and normalized to siCONT transfection. A two-tailed paired
Student’s t test was used to calculate statistical significance. Error bars represent 1 SD from themeanwithin three independent experiments. *p < 0.05; **p < 0.01;
***p < 0.001.
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Figure 4. RBM3 Regulates RTN3 In Vivo
(Ai) Cooling increases RBM3 and RTN3 levels in hippocampi of wild-typemice. Representative western blots are shown. Bar graphs show quantification of RBM3
and RTN3 levels relative to b-actin and GAPDH, respectively. n = 5 control and 5 cooled mice for RBM3. n = 9 control mice and 9 cooled mice for RTN3. *p < 0.05;
***p < 0.001
(Aii) qRT-PCR of RNA isolated from hippocampi of cooled mice showed no significant change in the abundance of RBM3 or RTN3 mRNAs following cooling.
(B) Protein synthesis rates were determined by 35Smethionine incorporation into nascent protein using ex vivo hippocampus slices from cooled mice and control
mice. A two-tailed paired Student’s t test was used to calculate statistical significance. Error bars represent 1 SD from the mean within three independent
experiments. *p < 0.05.
(C) Sucrose density gradient ultracentrifugation performed of cytoplasmic extracts from hippocampi from control and cooled mice. Absorbance plots show the
distribution of RNA within subpolysomes (40S, 60S, and 80S) and polysomes.
(D) RTN3 induction on in vivo cooling is dependent on RBM3 protein expression. Knockdown of RBM3 resulted in a 38% decrease in RTN3 induction. n = 6
LV-control and 6 LV-shRNA-RBM3 mice. **p < 0.01.(Figure 6A). To assess neuroprotective effects of RTN3 overex-
pression, we measured synapse number (Figure 6B), burrowing
activity (Figure 6C), and neuron number in CA1 of hippocampus
from diseased animals treated with LV-RTN3 compared to con-
trols (Figure 6D) over the time course of disease. All of these pa-
rameters decline in the course of prion disease in the absence of
intervention. Importantly, RTN3 overexpression restored syn-
apse number to wild-type levels, markedly above levels seen in
untreated mice at the same and later time points (Figure 6B),644 Current Biology 27, 638–650, March 6, 2017and prevented the decline in burrowing behavior (Figure 6C).
RTN3 overexpression also conferred marked neuroprotection
at the histological level, with very notable conservation of
the CA1 pyramidal neuron layer (Figure 6D). Importantly, LV-
RTN3 significantly increased survival of prion-infected mice (Fig-
ure 6E), recapitulating the effects of LV-RBM3 we previously
described [3]. In our study of RBM3, we showed that onset of
synaptic failure correlates with failure of induction of RBM3 at
6 w.p.i. [3]. And interestingly, RTN3 induction at this time point
Figure 5. Lentiviral-Mediated Downregulation of Endogenous RTN3 Prevents Cooling-Induced RBM3-Mediated Neuroprotection
(A) LV-shRNA-RTN3 injected into hippocampi of prion-infected mice significantly reduces RTN3 protein levels compared to control shRNA (LV-shCONT). n = 6
prion+LV-control mice and 6 prion+LV-shRNA-RTN3 mice. Representative western blots and bar graphs quantification are shown.
(B) Western blot of RBM3 in LV-shRNA-RTN3-treated early-cooled prion mice shows no change in expression. n = 6 mice per experimental condition.
(C) The early-cooling-induced protection in burrowing behavior declines in LV-shRNA-RTN3 mice. Food pellet remaining in the tube measured after 2 hr
is expressed in percentage burrowed. Graph bar with prion (black bars; n = 12 mice), prion + early cooling (gray bars; n = 20 mice), and prion + early
cooling + LV-shRNA-RTN3 (light brown bars; n = 12 mice) is shown. One-way ANOVA with Tukey’s post-test was used for multiple comparisons. *p < 0.05;
***p < 0005.
(D) Representative images of H&E-stained hippocampal sections from uninfected control (top left-hand panel), prion-infected mice (top right-hand panel), prion-
infectedmice treated with early cooling and LV-control (bottom left-hand panel), and prion-infectedmice treated with early cooling and LV-shRNA-RTN3 (bottom
right-hand panel). Prion-infected mice show extensive neuronal loss, with associated spongiosis, whereas early cooling treatment prevents neurodegeneration.
This protection is abrogated with LV-shRNA-RTN3. The graph bar shows quantification of the average number of neurons for each condition in the CA1 area of
hippocampus. n = 3 mice (white bar), 7 mice (black bar), 7 prion mice (bar), and 9 mice (light brown bar). One-way ANOVA and Brown-Forsythe test with Tukey’s
post hoc analysis for multiple comparisons were used. ***p < 0.001. The scale bar represents 50 mm.
(legend continued on next page)
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is also lost (Figure 6F), supporting a functional relationship be-
tween these proteins in the context of disease and loss of synap-
tic structural plasticity.
Misfolded PrP levels were not affected by cooling or RTN3
expression, and levels were equivalent in all mice, precluding a
mechanism of action via prion protein aggregation, consistent
with our previous findings with RBM3 [3] (Figure S5D).
Thus, RTN3 overexpression results in neuroprotection at the
level of synapse number, behavior, neuronal numbers, and
increased survival, downstream and independently of cooling-
mediated RBM3 induction.
DISCUSSION
Themetabolic response to cooling is highly conserved [3, 35, 42].
The neuroprotective effects of hypothermia are essential for
healthy brain function after hibernation and are widely exploited
medically [43, 44]. However, relatively little is known about how
global gene expression changes bring about these protective
effects.
We have examined the genome-wide changes induced by
cold stress by carrying out transcriptional, miRNA, and transla-
tional profiling on cells that were subjected to cooling. Our
data show that specific induction of gene expression during
cold stress is regulated at the level of translation with no signifi-
cant transcriptional upregulation or changes in miRNA expres-
sion (Figures 1, S1, and S2; Tables S1 and S2).
Elongation rate control is the major determinant of global pro-
tein synthesis suppression upon cooling [12], but which tran-
scripts are controlled in this way was unknown. We therefore
generated a computational model to predict those messages
that were particularly sensitive to regulation at this stage (Fig-
ure S3). According to our model, expression from transcripts
that require abundant tRNAs would be dependent on eEF2 to
maintain efficient elongation and protein expression. In contrast,
mRNAs requiring rare tRNAs would be proportionally less
affected by reductions in eEF2 availability and would be pre-
dicted to display either a small decrease or exhibit no net change
in polysomal association upon cooling (Figure S3). In support of
this hypothesis, the RTN3mRNA is decoded by rare tRNAs and,
following cooling, exhibited reduced polysomal-associated yet
increased protein expression (Figure 2). We showed that cis-
and trans-acting factors were required for RTN3 to overcome
cooling-induced translation inhibition (Figure 3) and that the
RNA chaperone RBM3 [6, 31, 32] was required (Figures 3 and 4).
We were interested in the functional consequence of RTN3
upregulation in response to cold shock. We have previously re-
ported that RBM3 mediates the neuroprotective effects of cool-
ing in mouse models of neurodegeneration and is necessary for
maintenance of synaptic structural plasticity [3]. How it does this
was not understood. We considered RTN3 to be a candidate
neuroprotective protein specifically upregulated by RBM3 in-
duction on cooling. In support of this, knockdown of RTN3
reduced synapse number at an earlier stage and abolished the(E) Early cooling prolongs survival in prion-infected mice but is abolished by knoc
cooled (black line); n = 14 cooled + shRNA of RTN3 (light brown line). One-way A
versus cooled mice ***p < 0.001; not cooled versus cooled + shRNA of RTN3 n.s
See also Figures 5C and 5D.
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despite cooling-induced increase in RBM3 levels (Figures 5
and S5C). Conversely, lentivirally mediated overexpression of
RTN3 prevented synapse loss and neurodegeneration in prion-
diseased mice (Figure 6), recapitulating the neuroprotective
effects observed during RBM3 expression [3].
In conclusion, we propose that, following cooling, there is
translational reprogramming, leading to the overexpression of
specific cold-inducible proteins, including the known cold shock
protein, RBM3, but also of RTN3. Critically, we show that induc-
tion of RTN3 is downstream of RBM3 expression, and our data
suggest that RTN3 is a mediator of the RBM3-driven neuropro-
tective effects of cooling in prion-diseased mice, most likely
through its multiple roles in the regulation of neurite outgrowth
and regulation of synaptic plasticity. It is likely that RTN3 induc-
tion would mediate a similar neuroprotective role in other neuro-
degenerative conditions. Further, its inhibition of BACE1-medi-
ated cleavage of APP could also contribute to neuroprotection
in Alzheimer’s pathology. We propose that the control of RTN3
expression through escape from inhibition of translation on cool-
ing at the levels of initiation and elongation provides new targets
for neuroprotective therapies in neurodegenerative disease.
EXPERIMENTAL PROCEDURES
All animal work was conducted according to UK Home Office Regulations. For
details of antibodies, plasmids, and oligonucleotides, please see the Supple-
mental Experimental Procedures.
Cell Culture and Transfections
HEK293 cells were cultured under standard conditions in DMEM supple-
mented with 10% fetal bovine serum (FBS). For induction of cold stress, cells
were incubated at 32C or at 25C for 24 hr before harvesting. Small interfering
RNAs (siRNAs) were transfected using DharmaFECT 1 and plasmids with
Lipofectamine 2000 (Invitrogen).
SDS-PAGE and Western Blotting
Western blots were performed as described previously [45] with modifications
described in the Supplemental Experimental Procedures.
Determination of Protein Synthesis Rates
The rate of protein synthesis was measured by the incorporation of 35S-methi-
onine into trichloroacetic acid (TCA)-insoluble material as described previ-
ously [10]. Further details are provided in the Supplemental Experimental
Procedures.
Sucrose Gradient Density Centrifugation and RNA Detection
Sucrose density gradient analysis was carried out as described [10]. Full de-
tails are provided in the Supplemental Experimental Procedures.
RNA Extraction
Total RNA extraction was performed using Trizol reagent (Invitrogen) accord-
ing to the manufacturer’s instructions.
Microarray Hybridization
The human cDNA microarrays were manufactured in Nottingham University.
This custom cDNA microarray consists of 29,593 (32,448 total, including
2,855 control probes) oligonucleotide probes derived from MWG Human
30K slides A, B, and C. RNA from sucrose density gradient fractionation waskdown of RTN3. Kaplan-Meier plot; n = 25 cooled mice (gray line); n = 17 not
NOVA with Tukey’s post-test was used for multiple comparisons; not cooled
.; cooled mice versus cooled + shRNA of RTN3 *p < 0.05.
Figure 6. Enhanced RTN3 Expression Is Sufficient to Protect against Prion Disease in the Absence of Cooling
(A) LV-RTN3 delivery to hippocampi of prion-infected mice increases RTN3 in the absence of cooling compared to control lentiviral treatment (LV-control)
and endogenous RBM3 (remain constant). n = 6 mice LV-control and 6 mice LV-shRNA-RTN3. Representative western blots and bar graphs quantification are
shown.
(B) LV-RTN3 protected the deficit in synapse loss in prion-infected mice at 7 and 9 w.p.i. Representative electron micrographs are shown, pseudo-colored for
ease of synapse identification: presynaptic, dark pink; postsynaptic, light pink. Bar chart quantification is shown. n = 93 images from three animals per condition.
Data represent mean ± SEM; t test; ***p < 0.0001. The scale bar represents 1 mm.
(C) RTN3 overexpression prevented the decline in burrowing behavior of prion–infectedmice. Food pellets remaining in the tube weremeasured after 2 hr and are
expressed as percentage burrowed. Graph bar with prion (black bars; n = 14 mice) and prion + LV-RTN3 (orange bars; n = 20 mice) is shown. Kruskal-Wallis test
with Dunn’s multiple comparisons test; **p < 0.01.
(D) Representative images of H&E-stained hippocampal sections from uninfected control, prion-infected mice with LV-control, and prion-infected mice with LV-
RTN3. The graph bar shows quantification of the average number of neurons for each condition in the CA1 area of hippocampus. n = 3 mice (white bar), 5 mice
(black bar), and 15mice (orange bar). One-way ANOVA and Brown-Forsythe test with Tukey’s post hoc analysis for multiple comparisons were used. ***p < 0.001.
The scale bars represent 400 mm (top row) and 50 mm (bottom row).
(legend continued on next page)
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pooled into subpolysomal or polysomal fractions, labeled, and hybridized to
the arrays as described previously [10]. Microarray slides were scanned using
a GenePix 4200B microarray scanner and GenePix Pro 6.0 software (Axon
Instruments).
Analysis of Microarray Data
GenePix Pro 6.0 was used to quantify fluorescence intensities for individual
spots on the microarray. All statistical analysis was performed in the statistical
environment R, version 2.6.1, and the Limma package [46].
Northern Blot
Northern analysis was performed as described previously [10]. Visualization
and quantification of northern blot analysis was performed using a Molecular
Imager FX phosphoimager and ImageJ software.
RNA-Protein Complex Immunoprecipitation
Post-nuclear extracts were incubated with either anti-RBM3 antibody or
immunoglobulin G (IgG)-coated protein G magnetic beads and processed as
described in the Supplemental Information.
Reverse Transcription and qPCR
Reverse transcriptionwas carried out using randomprimers and Superscript III
Reverse Transcriptase (Invitrogen) according to manufacturer instructions.
qPCR was carried out using SensiFAST SYBR Lo-ROX Kit (Bioline) accord-
ing to manufacturer instructions. Primers used are in the Supplemental
Information.
Prion Infection of Mice
As described previously [37], hemizygous tg37 mice of both sexes were inoc-
ulated with 1% brain homogenate of Chandler/RML prions at 3–6 weeks of
age. Control mice received 1% normal brain homogenate.
Induction of Hypothermia in Mice
FVB wild-type (WT) or hemizygous Tg37 mice weighing more than 20 g were
cooled using 50 AMP as described [3]. Prion-infected mice were injected
with lentiviruses at 2 w.p.i. and subsequently cooled at 3 and 4 w.p.i.
Lentiviruses and Mice Stereotaxic Surgery
GenTarget generated lentiviral plasmids. Viruses were injected stereotaxically
into the CA1 region of the hippocampus as described [3]; additional informa-
tion is provided in the Supplemental Information.
Burrowing
Burrowing was performed as described [3]. Briefly, mice were placed in a cage
with a tube full of pellets, which they ‘‘burrowed.’’ The extent of burrowing was
assessed by the weight of pellets displaced in 2 hr.
Histology
Paraffin-embedded brains and pancreases were sectioned at 5 mm and
stained with H&E as described [38, 39]. Neuronal counts were determined
by quantifying NeuN-positive pyramidal CA1 neurons as described [39]. Syn-
apses were counted in electron microscopy (EM) images of the stratum
radiatum of the hippocampal CA1 region, blind. A synapse was defined as a
structure with synaptic vesicles, synaptic cleft, and post-synaptic density,
as described [3].
Computational Modeling
Translation elongation rates on human mRNAs were estimated using a pub-
lished computational model [24]. The model was re-parameterized for the
human decoding system using relative total tRNA abundances from [47] and(E) LV-RTN3 significantly lengthened survival of prion-infected mice. Kaplan-Me
n = 15); t test; **p < 0.01.
(F) Induction of RTN3 fails at 6 w.p.i. in prion-diseased mice. Blue lines above the
mice. Bar graphs show quantification of RTN3 levels relative to GAPDH at 4 and 6
red bars from control mice. n = 9 mice per condition. *p < 0.05. Data are mean ±
648 Current Biology 27, 638–650, March 6, 2017a total tRNA concentration in HEK293 cells of 5.6 pg per cell, which was deter-
mined by comparing the staining intensity of the tRNA band in total RNA preps
from HEK293 cells to the intensity of bands generated with known amounts of
commercial yeast tRNA. Individual tRNA selection and translocation reactions
were modeled in PRISM [48] using rate constants [49] and tRNA ratios for in-
dividual codons [24] as published.
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